Amarin Corp Plc (AMRN)

[homebuilder_watcher]

JL, with all due respect, I think you are chasing ghosts on the inflammatory angle. I do not think that is going to come into play at all. Vascepa is going to be viewed as a better version of Lovaza, for marine use. Can they knock off the entrenched major player this year. Then comes ANCHOR. WIll docs embrace the ned for the drug for people who have TG levels above 200g and prescribe it without results from Reduce it. In other words, is there real evidence that lowering someone's TG from 200 to 150 makes a measurable impact on cardio health